Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald W Verhaegh

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|June 30, 2018
Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer riskAleksandra M Dudek, Sita H Vermeulen, Dimitar Kolev, et al.
Plos One|February 23, 2024
TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound libraryAmit Deshpande, Jan Brants, Christine Wasylyk, et al.
European Urology|February 12, 2008
Polymorphisms in the H19 gene and the risk of bladder cancerGerald W Verhaegh, Linda Verkleij, Sita H H M Vermeulen, et al.
Oncotarget|April 19, 2017
Identification of long non-coding RNAs that stimulate cell survival in bladder cancerAleksandra M Dudek, Sabrina J Boer, Nanda Boon, et al.
The Prostate|April 5, 2012
DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cellsMarleen Ansems, Nina Karthaus, Saartje Hontelez, et al.
International Journal of Molecular Sciences|May 27, 2023
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate CancerLevi Groen, Iris Kloots, David Englert, et al.
The Prostate|September 30, 2010
Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patientsGerald W Verhaegh, Arjan S de Jong, Frank P Smit, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment ResponseAnne J Grotenhuis, Aleksandra M Dudek, Gerald W Verhaegh, et al.
The Prostate|January 31, 2022
Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptidesMaria V Luna Velez, Omar Paulino da Silva Filho, Gerald W Verhaegh, et al.
The Prostate|August 27, 2009
Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancerDaphne Hessels, Martijn P M Q van Gils, Onno van Hooij, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cellular Oncology (Dordrecht, Netherlands)|June 30, 2018
Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer riskAleksandra M Dudek, Sita H Vermeulen, Dimitar Kolev, et al.
Plos One|February 23, 2024
TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound libraryAmit Deshpande, Jan Brants, Christine Wasylyk, et al.
European Urology|February 12, 2008
Polymorphisms in the H19 gene and the risk of bladder cancerGerald W Verhaegh, Linda Verkleij, Sita H H M Vermeulen, et al.
Oncotarget|April 19, 2017
Identification of long non-coding RNAs that stimulate cell survival in bladder cancerAleksandra M Dudek, Sabrina J Boer, Nanda Boon, et al.
The Prostate|April 5, 2012
DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cellsMarleen Ansems, Nina Karthaus, Saartje Hontelez, et al.
International Journal of Molecular Sciences|May 27, 2023
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate CancerLevi Groen, Iris Kloots, David Englert, et al.
The Prostate|September 30, 2010
Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patientsGerald W Verhaegh, Arjan S de Jong, Frank P Smit, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment ResponseAnne J Grotenhuis, Aleksandra M Dudek, Gerald W Verhaegh, et al.
The Prostate|January 31, 2022
Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptidesMaria V Luna Velez, Omar Paulino da Silva Filho, Gerald W Verhaegh, et al.
The Prostate|August 27, 2009
Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancerDaphne Hessels, Martijn P M Q van Gils, Onno van Hooij, et al.
Pageof 6